Publications 2024

  1. Bonfrate A, Ronga MG, Patriarca A, Heinrich S, De Marzi L. Monte Carlo modeling of a commercial machine and experimental setup for Flash-Minibeam irradiations with electrons. Med Phys, 1-11, 2024. DOI: https://doi.org/10.1002/mp.17492

  2. Granado-González M, Price T, Gonella L, Moustakas K, Hirono T, Hemperek T, De Marzi L, Patriarca A. First test beam of the DMAPS-based proton tracker at the pMBRT facility at the Curie Institute. Phys Med Biol. 69(21), 2024. DOI: 10.1088/1361-6560/ad84b3.

  3. Potiron S, Iturri L, Juchaux M, Espenon J, Gilbert C, McGarrigle J, Ortiz Catalan R, Fernandez-Rodriguez A, Sebrié C, Jourdain L, De Marzi L, Créhange G, Prezado Y. The significance of dose heterogeneity on the anti-tumor response of minibeam radiation therapy. Radiother Oncol. 201:110577, 2024. DOI: 10.1016/j.radonc.2024.110577.

  4. Renard S, Parent L, De Marzi L, Tsoutsou P, Kirova Y. Electron radiation therapy: Back to the future? Cancer Radiother. 28(6-7):553-559, 2024. DOI: 10.1016/j.canrad.2024.07.013.

  5. Gesualdi F, de Marzi L, Dutreix M, Favaudon V, Fouillade C, Heinrich S. A multidisciplinary view of flash irradiation. Cancer Radiother. 28(5):453-462, 2024. DOI: 10.1016/j.canrad.2024.07.003.

  6. Sitarz M, Ronga MG, Gesualdi F, Bonfrate A, Wahl N, De Marzi L. Implementation and validation of a very-high-energy electron model in the matRad treatment planning system. Med Phys, in press, 2024. DOI: 10.1002/mp.17392.

  7. Loap P, Vu-Bezin J, De Marzi L, Kirova Y. Proton therapy reduces the effective dose to immune cells in breast cancer patients. Strahlenther Onkol. in press, DOI: 10.1007/s00066-024-02263-1.

  8. González-Vegas R, Yousef I, Seksek O, Ortiz R, Bertho A, Juchaux M, Nauraye C, Marzi L, Patriarca A, Prezado Y, Martínez-Rovira I. Investigating the biochemical response of proton minibeam radiation therapy by means of synchrotron-based infrared microspectroscopy. Sci Rep. 14(1):11973, 2024. DOI: 10.1038/s41598-024-62373-9.

  9. Legdeur N, Badissi M, Venkatraghavan V, Woodworth DC, Orlhac F, Vidal JS, Barkhof F, Kawas CH, Visser PJ, Corrada MM, Muller M, Rhodius-Meester HFM. The temporal relation of physical function with cognition and the influence of brain health in the oldest-old: The UCI 90+ Study and EMIF-AD 90+ Study. Gerontology, in press, 2024.

  10. Seban RD, Champion L, De Moura A, Lerebours F, Loirat D, Pierga JY, Djerroudi L, Genevee T, Huchet V, Jehanno N, Bidard FC, Buvat I. Pre-treatment [18F]FDG PET/CT biomarkers for the prediction of antibody-drug conjugates efficacy in metastatic breast cancer, Eur J Nucl Med Mol Imaging, in press, 2024.

  11. Buvat I, Weber WA. Is ChatGPT a reliable ghostwriter? J Nucl Med, 65(10):1499-1502, 2024. DOI: 10.2967/jnumed.124.268341.

  12. Paty LP, Degueldre S, Provost C, Schmitt C, Trump L, Fouque J, Vriamont C, Valla F, Gendron T, Madar O. Development of a versatile [68Ga]Ga-FAPI-46 automated synthesis suitable to multi-elutions of germanium-68/gallium-68 generators. Front Chem, 12:1411312. Front Chem, 2024. DOI: 10.3389/fchem.2024.1411312. 

  13. Loap P, De Marzi L, Decroocq J, Birsen R, Johnson N, Deau Fischer B, Bouscary D, Kirova Y. Proton Therapy Reduces the Effective Dose to Immune Cells in Mediastinal Hodgkin Lymphoma Patients. Int J Part Ther, 13:100110, 2024. DOI: 10.1016/j.ijpt.2024.100110.

  14. Loap P, Vu-Bezin J, De Marzi L, Kirova Y. Proton therapy reduces the effective dose to immune cells in breast cancer patients. Strahlenther Onkol. in press, 2024. DOI: 10.1007/s00066-024-02263-1.

  15. Bertho A, Ortiz R, Maurin M, Juchaux M, Gilbert C, Espenon J, Ramasamy G, Patriarca A, De Marzi L, Pouzoulet F, Prezado Y. Thoracic Proton Minibeam Radiation Therapy: Tissue Preservation and Survival Advantage Over Conventional Proton Therapy. Int J Radiat Oncol Biol Phys, 120(2):579-592, 2024. DOI: 10.1016/j.ijrobp.2024.04.011.

  16. Massis H, Degombert MH, Dindart J, Lazard D, Trésallet C, Frouin F, Pillot-Loiseau C. Le rythme : un marqueur d’atteinte du nerf laryngé supérieur ? 35èmes Journées d'Études sur la Parole (JEP 2024) 31ème Conférence sur le Traitement Automatique des Langues Naturelles (TALN 2024) 26ème Rencontre des Étudiants Chercheurs en Informatique pour le Traitement Automatique des Langues (RECITAL 2024), Jul 2024, Toulouse, France. pp.461-469. https://inria.hal.science/hal-04623096

  17. Boellaard R*, Buvat I*, Nioche C, Ceriani L, Cottereau AS, Guerra L, Hicks RJ, Kanoun S, Kobe C, Loft A, Schöder H, Versari A, Coltin CA, Zwezerijnen GJC, Zijlstra JM, Mikhaeel NG, Gallamini A, El-Galaly TC, Hanoun C, Chauvie S, Ricci R, Zucca E, Meignan M, Barrington SF. International benchmark for total metabolic tumor volume measurement in baseline 18F-FDG PET/CT of lymphoma patients: a milestone towards clinical implementation. J Nucl Med, 65:1343-1348, 2024. DOI: 10.2967/jnumed.124.267789.

  18. Le TK, Comte V, Darcourt J, Razzouk-Cadet M, Rollet AC, Orlhac F, Humbert O. Performance and clinical impact of radiomics and 3D-CNN models for the diagnosis of neurodegenerative parkinsonian syndromes on [18F]-FDOPA PET. Clin Nuc Med, 
    49(10):924-930, 2024. DOI: 10.1097/RLU.0000000000005392.

  19. Captier N, Orlhac F, Hovhannisyan-Baghdasarian N, Luporsi M, Girard N, Buvat I. RadShap: an explanation tool for highlighting the contributions of multiple regions of interest to the prediction of radiomic models. J Nucl Med, 65:1307-1312, 2024. DOI: https://doi.org/10.2967/jnumed.124.267434

  20. Haberl D, Spielvogel CP, Orlhac F, Iommi D, Buvat I, Haug AR, Papp L. Multicenter PET Image Harmonization using Generative Adversarial Networks. Eur J Nucl Med Mol Imaging, 51:2532-2546, 2024. DOI: 10.1007/s00259-024-06708-8.

  21. Hovhannisyan-Baghdasarian N, Luporsi M, Captier N, Nioche C, Cuplov V, Woff E, Hegarat N, Livartowski A, Girard N, Buvat I, Orlhac F. New promising candidate prognostic biomarkers in [18F]FDG-PET images: evaluation in independent cohorts of NSCLC patients. J Nucl Med, 65:635-642, 2024. DOI: 10.2967/jnumed.123.266331

  22. Kocak B, Akinci D'Antonoli T, Mercaldo N, Alberich-Bavarri A, Baessler B, Ambrosini I, Andreychenko A, Bakas S, Beets-Tan R, Bressem K, Buvat I, Cannella R, Cappellini LA, Cavallo AU, Chepelev LL, Chu LCH, Demircioglu A, deSouza NM, Dietzel M, Fanni SC, Fedorov A, Fournier LS, Giannini V, Girometti R, Groot Lipman KBW, Kalarakis G, Kelly B, Klontas ME, Koh DM, Kotter E, Lee HY, Maas M, Marti-Bonmati L, Müller H, Obuchowski N, Orlhac F, Papanikolaou N, Petrash E, Pfaehler E, Pinto dos Santos D, Ponsiglione A, Sabater S, Sardanelli F, Seeböck P, Sijtema NM, Stanzione A, Traverso A, Ugga L, Vallières M, van Dijk LV, van Griethuysen JJM, van Hamersvelt RW, van Ooijen P, Vernuccio F, Wang A, Williams S, Witowski J, Zhang Z, Zwanenburg A, Cuocolo R. METhodological RadiomICs Score (METRICS): a quality scoring tool for radiomics research endorsed by EusoMII. Insights into Imaging, 15:8, 2024. DOI: https://doi.org/10.1186/s13244-023-01572-w 

  23. Fraioli F, Albert A, Boellaard R, Boscolo Galazzo I, Brendel M, Buvat I, Castellaro M, Cecchin D, Fernandez PA, Guedj E, Hammers A, Kaplar Z, Morbelli S, Papp L, Shi K, Tolboom N, Traub-Weidinger T, Verger A, Van Weehaeghe D, Yakushev I, Barthel M. Perspectives of the European Association of Nuclear Medicine on the role of artificial intelligence (AI) in molecular brain imaging. Eur J Nucl Med Mol Imaging, 51(4):1007-1011, 2024. DOI: 10.1007/s00259-023-06553-1

  24. Girum KB, Cottereau AS, Vercellino L, Rebaud L, Clerc J, Casasnovas O, Morschhauser F, Thieblemont C, Buvat I. Tumor location relative to the spleen is a prognostic factor in lymphoma patients: a demonstration from the REMARC trial. J Nucl Med, 65(2):313-319, 2024. DOI: 10.2967/jnumed.123.266322

  25. Cottereau AS , Rebaud L , Trotman J , Feugier P, Nastoupil LJ , Bachy E, Flinn IW, Haioun C,  Ysebaert L, Bartlett NL, Tilly H, Casasnovas O, Ricci R, Portugues C, Buvat I, Meignan M, Morschhauser F. Metabolic tumor volume predicts outcome in advanced stage follicular lymphoma patients from the Relevance trial. Ann Oncol, 35:130-137, 2024. DOI: https://doi.org/10.1016/j.annonc.2023.10.121

  26. Mahé M, Beddok A, Goudjil F, Ala Eddine C, Bolle S, Champion L, Feuvret L, Herman P, Zefkili S, Choussy O, Le Tourneau C, Dendale R, Buvat I, Sauvaget E, Créhange G, Calugaru V. Curative high-dose reirradiation for patients with recurrent head and neck adenoid cystic carcinomas: outcomes and analysis of patterns of failure. Int J Radiat Biol, 100:79-86, 2024. DOI: 10.1080/09553002.2023.2242934.

  27. Whybra P, Zwanenburg A, Andrearczyk V, Schaer R, Apte AP, Ayotte A, Baheti B, Bakas S, Bettinelli A, Boellaard R, Boldrini L, Buvat I, Cook GJR, Dietsche F, Dinapoli N, Gabryś HS, Goh V, Guckenberger M, Hatt M, Hosseinzadeh M, Iyer A, Lenkowicz J, Loutfi MAL, Löck A, Marturano A, Morin O, Nioche C, Orlhac F, Pati S, Rahmim A, Rezaeijo SM, Rookyard CG, Salmanpour MR, Schindele A, Shiri I, Spezi E, Tanadini-Lang S, Tixier F, Upadhaya T, Valentini V, van Griethuysen JJM, Yousefirizi F, Zaidi H,  Müller H, Vallières M, Depeursinge A. The Image Biomarker Standardization Initiative: Standardized Convolutional Filters for Reproducible Radiomics and Enhanced Clinical Insights. Radiology, 310: e231319, 2024. DOI: https://doi.org/10.1148/radiol.231319